News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Acorda Resubmits New Drug Application for INBRIJA™ (CVT-301, levodopa inhalation powder)


(December 7, 2017) - Acorda Therapeutics announced the resubmission of its New Drug Application for INBRIJA to the U.S. Food and Drug Administration. INBRIJA is an investigational treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen. Read more…